D’hONDT FARMA
ActiveSummary
D’hONDT FARMA has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €596,574 and a net result of €159,463. Equity has been growing by about 3.5% per year since 2018. Its solvency ranks better than 87% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 12-03-2001 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.100.260.529 9220 Hamme (Vl.), since 30-04-2001
- Financial year end
- 31 December
- Peppol
- Reachable since 07-10-2026
Board and ownership
- B&E BEHEERDirector · permanent representative Bavo Schelfhout
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €319,076
- ▼ 5.2%
- Turnover
- ≈ €1.2m
- estimated
- Profit
- €159,463
- ▲ 2.1%
- Equity
- €596,574
- ▼ 4.0%
- Total assets
- €776,363
- ▼ 13.3%
- Employees on 31-12-2025
- 1
- ▼ 50.0%
Score breakdownlowers riskEquity €596,574 (76.8% of total assets)Founded in 2001Liquidity: current ratio 3.65, cash €93,380Size: 1.4 FTE, total assets €776,363Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 92% of them on solvency, 64% on liquidity, 88% on profitability and 32% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 2 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Resignation: Marc D'hondt (director)Appointment: BV B&E BEHEER (director) · Permanent representative: Bavo Schelfhout
- · Gazette deed Change of role: D'HONDT Marc, from manager to directorPermanent representative: D'HONDT Marc
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as D’hONDT FARMA: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €621,000 and €899,000, founded between 1999 and 2006.
| Company | Total assets | Gross margin |
|---|---|---|
| D’hONDT FARMA Hamme (Vl.) | €776,363 | €319,076 |
| APOTHEEK LORMANS-NELISSEN Hasselt | €858,920 | €313,124 |
| PHARMACIE NEUJEAN Liège | €749,360 | €279,640 |
| APOTHEEK SOFIE DHONT Gavere | €692,188 | €360,858 |
| STEKENE PHARMA Stekene | €898,762 | €265,664 |
| HELDO Erpe-Mere | €621,357 | €310,545 |
| Apotheek Acke Maldegem | €668,623 | €307,140 |
Key facts about D’hONDT FARMA
- What is the company number of D’hONDT FARMA?
- The company number of D’hONDT FARMA is 0474.292.980. The VAT number is the same number with BE in front: BE 0474.292.980.
- Where is D’hONDT FARMA based?
- The registered office is at Filip De Pillecynlaan 1, 9220 Hamme (Vl.).Company details
- What does D’hONDT FARMA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of D’hONDT FARMA?
- The legal form of D’hONDT FARMA is Private limited company (BV).
- When was D’hONDT FARMA founded?
- D’hONDT FARMA was founded on 12-03-2001.
- Is D’hONDT FARMA still active?
- Yes, D’hONDT FARMA is an active enterprise in the KBO register.
- How many employees does D’hONDT FARMA have?
- D’hONDT FARMA had an average of 1.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does D’hONDT FARMA fall under?
- In its 2025 annual accounts, D’hONDT FARMA states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of D’hONDT FARMA?
- The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €319,076 and 47 comparable companies (NACE 477). It probably lies between €900,000 and €1.9m.
- Is D’hONDT FARMA profitable?
- In financial year 2025, D’hONDT FARMA made a profit of €159,463.
- Where can I find the annual accounts of D’hONDT FARMA?
- D’hONDT FARMA filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of D’hONDT FARMA due?
- D’hONDT FARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.